The Current Ratio as of December 2025 (TTM) for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) is 2.82

According to Chunghwa Chemical Synthesis & Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.82. This represents a change of -5.33% compared to the average of 2.97 of the last 4 quarters.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Historical Current Ratio (quarterly & annually)

How has 1762.TW Current Ratio performed in the past?

The mean historical Current Ratio of Chunghwa Chemical Synthesis & Biotech Co., Ltd. over the last ten years is 1.90. The current 2.82 Current Ratio has changed 14.72% with respect to the historical average. Over the past ten years (40 quarters), 1762.TW's Current Ratio was at its highest in in the December 2024 quarter at 3.39. The Current Ratio was at its lowest in in the September 2017 quarter at 0.74.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Average Current Ratio

How has 1762.TW Current Ratio performed in the past?

The current Current Ratio of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Current Ratio vs. Peers

How is 1762.TW’s Current Ratio compared to its peers?

Chunghwa Chemical Synthesis & Biotech Co., Ltd.’s Current Ratio is less than Advagene Biopharma Co., Ltd. (30.83), greater than Genomics BioSci & Tech. Co.,Ltd. (1.35), greater than Sunny Pharmtech Inc. (1.30), less than Greenyn Biotechnology Co., Ltd (6.47), greater than Meribank Biotech Co., Ltd (1.58), less than Hcmed (11.14), less than InnoPharmax Inc. (6.80), less than Shangya Technology Co., Ltd. (3.05), less than NaviFUS Corp. (15.39), greater than GlycoNex Incorporation (1.67),

Build a custom stock screener for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chunghwa Chemical Synthesis & Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chunghwa Chemical Synthesis & Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.